Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
The Journal of Biological Chemistry
|
March 12, 2011
Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization
Rebecca Feltham, Bodhi Bettjeman, Rhesa Budhidarmo, et al.
Science Signaling
|
September 27, 2018
Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1
Sam A Jamieson, Zheng Ruan, Abigail E Burgess, et al.
Structure (London, England : 1993)
|
September 15, 2022
Nanobodies identify an activated state of the TRIB2 pseudokinase
Sam A Jamieson, Michael Pudjihartono, Christopher R Horne, et al.
Journal of Lipid Research
|
December 7, 2019
Nonsynonymous SNPs in <i>LPA</i> homologous to plasminogen deficiency mutants represent novel null apo(a) alleles
Benjamin M Morgan, Aimee N Brown, Nikita Deo, et al.
Science Signaling
|
March 12, 2020
Structure-based mechanism of preferential complex formation by apoptosis signal-regulating kinases
Sarah J Trevelyan, Jodi L Brewster, Abigail E Burgess, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 8, 2013
Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAP
Robert J Ardecky, Kate Welsh, Darren Finlay, et al.
Science Advances
|
February 26, 2025
DET1 dynamics underlie cooperative ubiquitination by CRL4<sup>DET1-COP1</sup> complexes
Abigail E Burgess, Tarren A Loughran, Liam S Turk, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 18, 2011
Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP
Marcos González-López, Kate Welsh, Darren Finlay, et al.
ACS Chemical Biology
|
January 18, 2013
Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP
Mitchell Vamos, Kate Welsh, Darren Finlay, et al.
The Journal of Biological Chemistry
|
October 10, 2009
TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis
James E Vince, Delara Pantaki, Rebecca Feltham, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
The Journal of Biological Chemistry
|
March 12, 2011
Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization
Rebecca Feltham, Bodhi Bettjeman, Rhesa Budhidarmo, et al.
Science Signaling
|
September 27, 2018
Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1
Sam A Jamieson, Zheng Ruan, Abigail E Burgess, et al.
Structure (London, England : 1993)
|
September 15, 2022
Nanobodies identify an activated state of the TRIB2 pseudokinase
Sam A Jamieson, Michael Pudjihartono, Christopher R Horne, et al.
Journal of Lipid Research
|
December 7, 2019
Nonsynonymous SNPs in <i>LPA</i> homologous to plasminogen deficiency mutants represent novel null apo(a) alleles
Benjamin M Morgan, Aimee N Brown, Nikita Deo, et al.
Science Signaling
|
March 12, 2020
Structure-based mechanism of preferential complex formation by apoptosis signal-regulating kinases
Sarah J Trevelyan, Jodi L Brewster, Abigail E Burgess, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 8, 2013
Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAP
Robert J Ardecky, Kate Welsh, Darren Finlay, et al.
Science Advances
|
February 26, 2025
DET1 dynamics underlie cooperative ubiquitination by CRL4<sup>DET1-COP1</sup> complexes
Abigail E Burgess, Tarren A Loughran, Liam S Turk, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 18, 2011
Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP
Marcos González-López, Kate Welsh, Darren Finlay, et al.
ACS Chemical Biology
|
January 18, 2013
Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP
Mitchell Vamos, Kate Welsh, Darren Finlay, et al.
The Journal of Biological Chemistry
|
October 10, 2009
TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis
James E Vince, Delara Pantaki, Rebecca Feltham, et al.
Page
of 6